MORRIS GABRIEL S (Chief Financial Officer) purchased 0.9% of their position (2.50K shares) of IMMIX BIOPHARMA, INC. on the open market
Open‑market purchase worth $5.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/10/2024ACC: 0001493152-24-023288
DirectorOfficer· Chief Financial Officer
Since Dec 2021
+2.50K
Net shares
Net buyer
$5.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.50K
Price / share
$2.12
Trade value
$5.30K
% of position
0.9%
6/7/2024
283.33K→285.83K
Total
Net shares
+2.50K
Net value
$5.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/7/2024 | P · Purchase | +2.50K | $2.12 | $5.30K | 0.9% | 283.33K | 285.83K |
| Total | +2.50K | $5.30K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned270.84K
Common Stock
IndirectShares owned24.14K
Total
294.99K indirect294.99K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 270.84K | Indirect |
| Common Stock | 24.14K | Indirect |
| Total | 294.99K | 294.99K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported